Skip to content

RESHAPE LIFESCIENCES INC.: 10-K filed 2012-03-15

What RESHAPE LIFESCIENCES INC. reported in its annual report filed 2012-03-15 (fiscal FY 2011): 30 published measures, 100 facts as tagged in accession 0001193125-12-116517.

This filing

Form
10-K (annual report)
Filed
2012-03-15
Fiscal period
fiscal FY 2011
Accession
0001193125-12-116517 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All RESHAPE LIFESCIENCES INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-12-3132,485,855USD
At 2010-12-3138,687,265USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-12-3112,444,950USD
At 2010-12-318,980,208USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-12-3120,040,905USD
At 2010-12-3129,707,057USD
At 2009-12-315,581,110USD
At 2008-12-3111,405,144USD
At 2007-12-3145,281,520USD
At 2006-12-3128,573,772USD
At 2005-12-311,974,552USD
At 2004-12-315,327,418USD
At 2003-12-31-669,681USD
At 2002-12-3120,000USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-12-3128,487,688USD
At 2010-12-3130,840,560USD
At 2009-12-3114,617,594USD
At 2008-12-3121,055,108USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-25,997,322USD365
2002-12-19 to 2011-12-31-176,581,341USD3300
2010-01-01 to 2010-12-31-17,347,387USD365
2009-01-01 to 2009-12-31-31,929,200USD365
2008-01-01 to 2008-12-31-37,874,028USD366
2007-01-01 to 2007-12-31-28,575,348USD365
2006-01-01 to 2006-12-31-17,690,477USD365
2005-01-01 to 2005-12-31-11,215,191USD365
2004-01-01 to 2004-12-31-3,448,752USD366
2003-01-01 to 2003-12-31-1,900,288USD365
2002-01-01 to 2002-12-31-603,348USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-19,935,434USD365
2002-12-19 to 2011-12-31-147,183,157USD3300
2010-01-01 to 2010-12-31-13,664,607USD365
2009-01-01 to 2009-12-31-24,657,223USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-01-01 to 2011-12-31252,274USD365
2002-12-19 to 2011-12-312,831,222USD3300
2010-01-01 to 2010-12-312,592USD365
2009-01-01 to 2009-12-31186,981USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-12-3112,515,785USD365
2002-12-19 to 2011-12-31179,401,996USD3300
2010-01-01 to 2010-12-3136,417,196USD365
2009-01-01 to 2009-12-3113,180,690USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-12-315,066,777USD365
2002-12-19 to 2011-12-31-3,731,151USD3300
2010-01-01 to 2010-12-31-6,529,623USD365
2009-01-01 to 2009-12-315,039,019USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-12-31-176,712,309USD
At 2010-12-31-150,714,987USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-12-31630,354USD
At 2010-12-31741,564USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-01-01 to 2011-12-312,892,696USD365
2002-12-19 to 2011-12-3114,463,166USD3300
2010-01-01 to 2010-12-312,564,226USD365
2009-01-01 to 2009-12-312,439,291USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-12-3131,566,521USD
At 2010-12-3137,804,129USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-12-319,563,789USD
At 2010-12-313,997,049USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-12-31434,436USD
At 2010-12-31125,188USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-01-01 to 2011-12-3125,256,585USD365
2002-12-19 to 2011-12-31164,950,544USD3300
2010-01-01 to 2010-12-3116,177,116USD365
2009-01-01 to 2009-12-3124,212,343USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2011-12-311,068,623USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2011-01-01 to 2011-12-318,583,347USD365
2002-12-19 to 2011-12-3148,168,970USD3300
2010-01-01 to 2010-12-317,678,259USD365
2009-01-01 to 2009-12-318,631,597USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-01-01 to 2011-12-3116,673,238USD365
2002-12-19 to 2011-12-31116,781,574USD3300
2010-01-01 to 2010-12-318,498,857USD365
2009-01-01 to 2009-12-3115,580,746USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-12-3136,752,746shares
At 2010-12-3127,892,388shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-12-31196,384,995USD
At 2010-12-31180,143,120USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2011-12-31692USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2011-12-31288,980USD
At 2010-12-31141,572USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2011-12-316,373,370USD
At 2010-12-312,538,371USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2011-12-31804,799USD
At 2010-12-31436,538USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-25,996,630USD365
2009-01-01 to 2009-12-31-31,942,188USD365
2008-01-01 to 2008-12-31-37,861,040USD366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2011-01-01 to 2011-12-31303,972USD365
2002-12-19 to 2011-12-312,260,038USD3300
2010-01-01 to 2010-12-31375,756USD365
2009-01-01 to 2009-12-31424,354USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-30,119USD365
2002-12-19 to 2011-12-31-263,668USD3300
2010-01-01 to 2010-12-31-76,296USD365
2009-01-01 to 2009-12-31-47,363USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-12-311,068,623USD365
2002-12-19 to 2011-12-311,068,623USD3300

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-12-31367,491USD365
2002-12-19 to 2011-12-31301,140USD3300
2010-01-01 to 2010-12-31-109,950USD365
2009-01-01 to 2009-12-31-73,709USD365

Inspect the source

Entity
RESHAPE LIFESCIENCES INC. / CIK 0001371217
Captured
SEC response SHA-256
342900799b6d8ad7d662fb719941027b7ec7f1c6df6a2cd8acf7226229080bfa

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001371217.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))